TRELLUS HEALTH LS -0006 (85Q) — Working Capital to Net Assets Ratio
TRELLUS HEALTH LS -0006 (85Q) has a Working Capital to Net Assets ratio of 15.5% as of June 2025. Working capital of €1.35 Million (current assets of €1.86 Million minus current liabilities of €513.00K) is measured against net assets of €8.71 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 85Q financial flexibility score to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
TRELLUS HEALTH LS -0006 Working Capital to Net Assets (2021–2024)
This chart shows how TRELLUS HEALTH LS -0006's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 15.5%, reflecting working capital of €1.35 Million against net assets of €8.71 Million EUR. See 85Q days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for TRELLUS HEALTH LS -0006 (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for TRELLUS HEALTH LS -0006 from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 85Q company net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 35.2% | €4.14 Million | €11.77 Million | €4.51 Million | €371.00K | ▼ -24.0 pp |
| 2023 | 59.2% | €11.54 Million | €19.50 Million | €12.33 Million | €786.00K | ▼ -14.7 pp |
| 2022 | 73.9% | €18.55 Million | €25.09 Million | €19.37 Million | €822.00K | ▼ -13.7 pp |
| 2021 | 87.6% | €30.91 Million | €35.27 Million | €32.43 Million | €1.52 Million | — |